Myovant Sciences Ltd (MYOV): Had to re-read the last PR to also under...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	21
Posts	1676
Boards Moderated	0
Alias Born	07/09/2005

stockguard

Re: None

Sunday, 04/26/2020 5:22:23 PM

Sunday, April 26, 2020 5:22:23 PM

Had to re-read the last PR to also understand that Relugolix combination therapy could possibility be used as a new form of a safe birth control too.

Myovant Sciences Announces Positive Results from Phase 3 SPIRIT 2 Study Evaluating Once-Daily Relugolix Combination Therapy in Women with Endometriosis and from Ovulation Inhibition Study
April 22, 2020

Myovant also announced that, in a separate clinical study, relugolix combination therapy achieved 100% ovulation inhibition in 67 healthy women with no women ovulating during the 84-day treatment period, as evaluated by the Hoogland-Skouby assessment scale (score < 5). Furthermore, 100% of women resumed ovulation or menses upon discontinuation of treatment with an average time to ovulation of 23.5 days.

https://investors.myovant.com/news-releases/news-release-details/myovant-sciences-announces-positive-results-phase-3-spirit-2/